Dr. Dutta received his Ph.D. in 2004 from Jadavpur University, India, and did his early postdoctoral research at the College of Veterinary Medicine, Seoul National University, Seoul, South Korea, and Tulane National Primate Research Center, Tulane University, New Orleans, LA. After completing senior postdoctoral fellowship at the Center for Tuberculosis Research, Johns Hopkins School of Medicine, Baltimore, MD, he joined the Department of Medicine faculty in 2015. Dr. Dutta has significant expertise in microbiology, molecular biology, and animal models of TB infection.
He is a member of the Editorial Board of Frontiers in Antimicrobials, Resistance and Chemotherapy; American Journal of Microbiological Research; The International Arabic Journal of Antimicrobial agents; Advances in Medicine, Austin Tuberculosis: Research & Treatment; Journal of Vaccines Research & Vaccination; World Journal of Clinical Infectious Diseases; Clinical Reviews and Opinions; WebmedCentral plus Infectious Diseases; Journal of Bacteriology & Mycology; and SOJ Microbiology & Infectious Diseases.
His research focuses on characterizing the efficacy of novel drugs and drug combinations against M. tuberculosis in murine and guinea pig models, with the goal of shortening the duration of TB chemotherapy. He is using multidisciplinary techniques, including computational modeling and high-throughput genetic screens in various animal models, including nonhuman primates, in order to elucidate M. tuberculosis essential pathways involved in latency and reactivation, as well as detection of TB biomarkers in people with HIV infection. He has published over 60 peer-reviewed papers on relevant topics.
Microbiology; Molecular biology and Animal models of TB infection; Antimicrobials; Resistance and Chemotherapy; Bacteriology; Mycology; Characterizing the efficacy of novel drugs and drug combinations against M. tuberculosis in murine and guinea pig models.